Fact CheckerSign in

NCT06806371Active, not recruiting

PREDICTORS of CARDIOVASCULAR OUTCOMES in INDIVIDUALS with DIFFERENT OBESITY PHENOTYPES

Source: ClinicalTrials.gov · Last updated 7 Feb 2025

Brief summary (registry, in English)

The aim of this observational study is to identify and evaluate adverse cardiovascular outcomes in metabolically healthy obese individuals in a cohort of 25 to 64 years of age, both men and women. The main questions it aims to answer are: what are the markers of adverse cardiovascular outcomes in metabolically healthy obese individuals?

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
1600 (estimated)
First submitted
28 Jan 2025
Start date
9 Jan 2023
Primary completion date
29 Dec 2027
Lead sponsor
Ryazan State Medical University
Diseases
Obesity
NCT number
NCT06806371

What you commit to

  • Study type: Observational
  • Planned participants: 1600
  • From 9 Jan 2023 to the primary completion date, 29 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • signs of chronic heart failure,
  • coronary heart disease,
  • heart disease or valve disease, which can be expected to lead to surgery during the study,
  • cancer.

Other

  • The presence of
  • infiltrative or hypertrophic obstructive cardiomyopathy or constrictive pericarditis,

Criteria the registry did not label

  • Inc1. Body mass index \>=30 kg/m2 . 2. Less than three of the five criteria according to The National Cholesterol Education Program's Adult Treatment Panel III, NCEP/ATP III):
  • Systolic blood pressure \>130 and/or diastolic blood pressure \>85 mmHg,
  • Triglycerides \>1.7 mmol/L,
  • High density lipoproteins \< 1.03 (men), \< 1.29 (women);
  • fasting plasma glucose \>=5.6 mmol/L,
  • waist circumference \>102 cm (men), \>88 cm (women)lusion Criteria:

Age in the registry: 25 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ryazan State Medical University
Coordinator of this site? Confirm its status		RyazanRussiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.